Aldeyra Therapeutics (ALDX) Net Shares Issued and Repurchased (2013 - 2026)

Aldeyra Therapeutics (ALDX) has reported Net Shares Issued and Repurchased for 14 consecutive years, with $2.1 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Net Shares Issued and Repurchased rose 96.3% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 96.3% YoY), and the FY2025 full-year result was $1.6 million, down 32.31% from the prior year.
• Net Shares Issued and Repurchased rose to $2.1 million in Q1 2026 per ALDX's latest filing, from $1.6 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $2.4 million in Q4 2024 and bottomed at $1.0 million in Q1 2023.
• Historically, Net Shares Issued and Repurchased has averaged $1.6 million across 5 years, with a median of $1.6 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Net Shares Issued and Repurchased soared 326.7% in 2022, then tumbled 48.15% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $1.8 million in 2022, then slumped by 33.22% to $1.2 million in 2023, then surged by 102.62% to $2.4 million in 2024, then tumbled by 32.31% to $1.6 million in 2025, then jumped by 32.97% to $2.1 million in 2026.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $2.1 million, $1.6 million, and $1.1 million for Q1 2026, Q4 2025, and Q1 2025 respectively.